(Q43033110)

English

A randomized, controlled trial to determine whether continued ribavirin monotherapy in hepatitis C virus-infected patients who responded to interferon-ribavirin combination therapy will enhance sustained virologic response

scientific article published on 16 July 2001

Statements

A randomized, controlled trial to determine whether continued ribavirin monotherapy in hepatitis C virus-infected patients who responded to interferon-ribavirin combination therapy will enhance sustained virologic response (English)
16 July 2001
405-409

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit